How does heart-failure risk change after quitting smoking?

01

Was heart failure already present when the study began?

Heart failure means the heart cannot pump blood properly; it does not mean the heart has stopped. Research on people without previous heart failure asks whether a new event occurs. In ARIC, the event was a physician-confirmed hospitalisation for acute decompensated heart failure. The Korean study identified a first admission with heart failure as the main diagnosis. Neither captured every possible early or outpatient case.

A separate 2001 analysis studied people with existing left-ventricular dysfunction and compared death and heart-failure admissions across smoking groups. It was a smoking-status comparison within drug trials, not a randomised trial of quitting. That population cannot be substituted for adults initially free of heart failure, nor can its outcomes show that an individual's pumping function recovers.

[2][3][5][6]

02

Two apparently conflicting numbers have different reference groups

The Korean cohort included 778,608 people who smoked at their 2009 health check and returned in 2011. Over a median 6.3 years, self-reported quitters had an adjusted hazard ratio (HR) of 0.86 (95% confidence interval 0.83–0.90) against people maintaining roughly their smoking amount. HR compares event rates over follow-up among people who have not yet had the event; 1 means no difference. It is not a 14-percentage-point reduction in someone's probability.

ARIC followed 9,345 US adults aged 61–81 without previous heart failure, with 1,215 first hospitalizations for acute heart failure over a median 13 years. Compared with never smokers, people in the 20-to-less-than-30-years cessation category still had an overall-HF HR of 1.34 (1.07–1.67). This asks about residual exposure, not whether stopping is worse than continuing.

The studies differ in age, selection, smoking measurement and how admissions were confirmed. Their estimates must not be divided, averaged or used to announce a universal year when risk ‘resets’. The ARIC year bands describe group comparisons; a person does not cross a biological switch at an anniversary.

[2][3]

03

The evidence did not stop in 2020

The 2020 Surgeon General report judged evidence suggestive but insufficient for a causal conclusion about lower incident heart-failure risk, and separately about survival and admissions after heart dysfunction. That is a dated assessment, not a claim that later research does not exist. The 2022 ARIC and 2023 Korean publications add substantial observational evidence; a 2024 Jackson Heart Study analysis also linked longer cessation to fewer new HF admissions in a cohort of Black adults without HF or coronary disease.

ARIC and Jackson considered heart failure with preserved or reduced ejection fraction—research subtypes, not instructions to interpret your scan. Smoking was self-reported, and confounding can remain after adjustment. ARIC had missing subtype information and gaps in some measurements; Jackson used baseline smoking information and one geographic population. Korea selected people attending two checks and used admission codes. These are not random assignments to quit, and they do not establish the same precise timeline for every subtype or population.

[1][2][3][4]

04

Use the distinction in a medical conversation, not a risk calculator

A useful question is: ‘Does this study concern people before heart failure, or people already receiving care—and does it count first admission, readmission or death?’ If heart failure has already been diagnosed, keep those questions with the treating team. A smoking comparison does not determine ejection fraction, medication changes, fluid intake or what current symptoms mean.

In England, NHS local stop-smoking services are a separate support route; confirm local access. New or persistent concerns need medical assessment rather than waiting for a smoke-free anniversary. This page does not request symptoms, scan results, smoking history or a quit date.

[2][3][5][6][7]

05

What to keep in mind

• First HF admission, readmission and survival are different outcomes.
• Continued smokers and never smokers are different reference groups.
• Newer cohorts supplement the dated 2020 assessment, not a personal prognosis.
• Neither a year band nor an HR tells you when the heart has recovered.